Attenuation of allergic airway inflammation and associated pulmonary functions by mycobacterial antigens is independent of IgE in a mouse model of asthma

ABSTRACT Background Since the observation that Bacillus Calmette–Guerin (BCG) vaccination in children correlates with a decreased prevalence of asthma, several investigators have been attempting to reproduce this effect experimentally in mouse models of asthma. While these reports have agreed in some areas, uncertainty has remained as to the effect of BCG on IgE and asthmatic response in general. Furthermore, the effect of mycobacterial antigens on the early allergic response and the release of bronchoconstrictory mediators have not been examined. In the present study, we have aimed to more completely describe the effect of BCG and Mycobacterium vaccae on early and late allergic responses (EAR and LAR, respectively), airway hyperresponsiveness (AHR) and broncho-constrictory mediators in the mouse model of allergic airway inflammation. Methods Using BALB/c mice sensitized to ovalbumin (OVA) and treated twice with either BCG or M. vaccae (1 × 10 5 CFU, intranasally), we investigated airway resistance of both the EAR and LAR, AHR to methacholine, serum total and antigen-specific IgE, cysteinyl leukotrienes in bronchoalveolar lavage (BAL) fluid (10 min following challenge), a complete cell differential of the BAL (24 h post-challenge), BAL and serum cytokines and lung histology. Results Neither BCG nor M. vaccae were able to attenuate the EAR, yet both were able to abrogate the parameters used to evaluate the LAR. Interestingly, in neither case were serum or OVA-specific IgE levels reduced after treatment with mycobacterial antigens and type 1/type 2 T cell cytokine skewing, based on cytokine levels in BAL and serum, was incomplete. Conclusions These results have led us to conclude that the mycobacterial antigens elicit potential anti-asthmatic effects independent of changes in IgE levels. We speculate that mycobacteria likely directly or indirectly suppress eosinophil effector function via attenuation of type 2 T cell-mediated immune responses.

[1]  S. Parr,et al.  Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. , 2001, International immunopharmacology.

[2]  R. Geha,et al.  IgE regulation and roles in asthma pathogenesis. , 2001, The Journal of allergy and clinical immunology.

[3]  S. Romagnani,et al.  T-cell subsets (Th1 versus Th2). , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  G. Gleich.  Mechanisms of eosinophil-associated inflammation. , 2000, The Journal of allergy and clinical immunology.

[5]  I. Barlan,et al.  Heat-Killed Mycobacterium bovis-Bacillus Calmette Guerin-Suppressed Total Serum IgE Response in Ovalbumin-Sensitized Newborn Mice , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  R. Tanaka,et al.  Noninvasive system for evaluating the allergen-specific airway response in a murine model of asthma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[7]  Zhu,et al.  Systemic mycobacterial infection inhibits antigen‐specific immunoglobulin E production, bronchial mucus production and eosinophilic inflammation induced by allergen , 1999, Immunology.

[8]  T. Morokata,et al.  C57BL/6 mice are more susceptible to antigen‐induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses , 1999, Immunology.

[9]  A. Kisselgof,et al.  Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. , 1999, American journal of respiratory and critical care medicine.

[10]  G. Cieslewicz,et al.  The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. , 1999, The Journal of clinical investigation.

[11]  Mohapatra,et al.  A recombinant BCG vaccine generates a Th1‐like response and inhibits IgE synthesis in BALB/c mice , 1999, Immunology.

[12]  D. Collie,et al.  Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. , 1999, American journal of respiratory cell and molecular biology.

[13]  K. Shirato,et al.  Ovalbumin (OVA) and Mycobacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper (Th) cells toward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia. , 1999, American journal of respiratory cell and molecular biology.

[14]  M. O'Donnell,et al.  BCG immunotherapy of bladder cancer: 20 years on , 1999, The Lancet.

[15]  S. Akira,et al.  Role of Interleukin-18 (IL-18) in Mycobacterial Infection in IL-18-Gene-Disrupted Mice , 1999, Infection and Immunity.

[16]  I. Barlan,et al.  Effect of pre‐immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin‐sensitized newborn mice , 1999, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[17]  E. Gelfand,et al.  Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness – a murine model , 1999, Allergy.

[18]  M. Fujita,et al.  Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. , 1999, European journal of pharmacology.

[19]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[20]  S. Uhlig,et al.  Characterization of airway and vascular responses in murine lungs , 1999, British journal of pharmacology.

[21]  U. Wahn,et al.  BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. , 1998, The Journal of allergy and clinical immunology.

[22]  M. Kool,et al.  Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. , 1998, Journal of immunology.

[23]  N. Krug,et al.  Frequencies of T cells expressing interleukin-4 and interleukin-5 in atopic asthmatic children. Comparison with atopic asthmatic adults. , 1998, American journal of respiratory and critical care medicine.

[24]  P. Henricks,et al.  Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5‐HT receptor antagonists in a mouse model of allergic asthma , 1998, British journal of pharmacology.

[25]  W. Busse.  Leukotrienes and inflammation. , 1998, American journal of respiratory and critical care medicine.

[26]  D. Agrawal,et al.  Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. , 1998, Journal of pharmacological and toxicological methods.

[27]  G. Rook,et al.  Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae , 1998, Immunology.

[28]  J. Holloway,et al.  Infection of Mice with Mycobacterium bovis–Bacillus Calmette-Guérin (BCG) Suppresses Allergen-induced Airway Eosinophilia , 1998, The Journal of experimental medicine.

[29]  M. Wills-Karp,et al.  The genetics of allergen-induced airway hyperresponsiveness in mice. , 1997, American journal of respiratory and critical care medicine.

[30]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[31]  A. Halayko,et al.  Airway responsiveness in two inbred strains of mouse disparate in IgE and IL-4 production. , 1997, American journal of respiratory cell and molecular biology.

[32]  P. Foster,et al.  Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. , 1997, The Journal of clinical investigation.

[33]  E. Gelfand,et al.  Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. , 1997, American journal of respiratory and critical care medicine.

[34]  E. Chi,et al.  Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. , 1997, American journal of respiratory and critical care medicine.

[35]  T. Shirakawa,et al.  The Inverse Association Between Tuberculin Responses and Atopic Disorder , 1996, Science.

[36]  E. Chi,et al.  The importance of leukotrienes in airway inflammation in a mouse model of asthma , 1996, The Journal of experimental medicine.

[37]  K. Murphy,et al.  Role of cytokines in determining T-lymphocyte function. , 1994, Current opinion in immunology.

[38]  D. Radzioch,et al.  T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice. , 1994, Immunology.

[39]  F. Luscinskas,et al.  IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. , 1992, Journal of immunology.

[40]  H. Sluiter,et al.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.

[41]  J. Drazen,et al.  Mouse models of airway responsiveness: physiological basis of observed outcomes and analysis of selected examples using these outcome indicators. , 1999, Annual review of physiology.

[42]  C. Corrigan,et al.  T cells and eosinophils in the pathogenesis of asthma. , 1992, Immunology today.